Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Rani Therapeutics

Rani Therapeutics

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

All edits

Edits on 19 Sep, 2022
Katrina-Kay Pettitt"prospector:1906:1373236"
Katrina-Kay Pettitt edited on 19 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Edits on 28 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 28 Jul, 2022
Edits made to:
Timeline
Timeline

March 7, 2018

On February 7, 2018 Rani Therapeutics completed a venture funding round with $53 million in funding from Shire (lead investor), GeneScience Pharmaceuticals (lead investor), Cathey Venture (lead investor), Bossa Ventures (lead investor), Virtus Inspire Ventures, Ping An Ventures, Google Ventures, and AstraZeneca.

September 9, 2017

On September 9, 2017 Rani Therapeutics completed their series D funding round with $39 million in funding from Google Ventures (lead investor), Novartis, and AstraZeneca.

May 26, 2015

On May 26, 2015 Rani Therapeutics completed their series C funding round with $37.5 million in funding from Western Life Sciences Venture Fund, VentureHealth, The Stevanato Group, Pinemount Investment, Pacific Venture Opportunity Fund, Novartis, InCube Ventures, Google Ventures, and Crystal Horizon Investments.

July 28, 2013

On July 28, 2013 Rani Therapeutics completed their series B funding round with $9.4 million in funding from Google Ventures (lead investor) and InCube Ventures.

June 13, 2012

On June 13, 2012 Rani Therapeutics completed their series A funding round with $4 million in funding from InCube Ventures.

Edits on 28 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 28 Jul, 2022
Edits made to:
Article
Article

On June 13, 2012 Rani Therapeutics completed their series A funding round with $4 million in funding from InCube Ventures.

...

On July 28, 2013 Rani Therapeutics completed their series B funding round with $9.4 million in funding from Google Ventures (lead investor) and InCube Ventures.

...

On May 26, 2015 Rani Therapeutics completed their series C funding round with $37.5 million in funding from Western Life Sciences Venture Fund, VentureHealth, The Stevanato Group, Pinemount Investment, Pacific Venture Opportunity Fund, Novartis, InCube Ventures, Google Ventures, and Crystal Horizon Investments.

...

On September 9, 2017 Rani Therapeutics completed their series D funding round with $39 million in funding from Google Ventures (lead investor), Novartis, and AstraZeneca.

...

On February 7, 2018 Rani Therapeutics completed a venture funding round with $53 million in funding from Shire (lead investor), GeneScience Pharmaceuticals (lead investor), Cathey Venture (lead investor), Bossa Ventures (lead investor), Virtus Inspire Ventures, Ping An Ventures, Google Ventures, and AstraZeneca.

Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 27 Jul, 2022
Infobox
Date incorporated
2012
Founded date
2012
Edits on 24 Jul, 2022
Alexander Baychikov
Alexander Baychikov edited on 24 Jul, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Number of employees
91
Golden AI"clean up phone number value"
Golden AI edited on 23 Jul, 2022
Edits made to:
Infobox (+1/-1 properties)
Infobox
Phone number
408-457-3700
Phone number
+14084573700
Edits on 5 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 5 Jul, 2022
Edits made to:
Article
Article

Edits on 5 Jun, 2022
Duzenko Andrey
Duzenko Andrey edited on 5 Jun, 2022
Infobox
Edits on 4 Jun, 2022
N Ni
N Ni edited on 4 Jun, 2022
Edits made to:
Infobox (+7/-1 properties)
Infobox
Email address
info@ranitherapeutics.com
media@ranitherapeutics.com
partners@ranitherapeutics.com
Full address
2051 Ringwood Ave. San Jose CA, 95131, USA
Investors
Legal name
Rani Therapeutics Holdings, Inc.
Email address
investors@ranitherapeutics.com
Number of Employees (ranges)
100 – 249
Exchange
Ticker symbol
RANI
Edits on 26 May, 2022
Pavel Alekseevich
Pavel Alekseevich edited on 26 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
B2X
Edits on 17 May, 2022
Katrina-Kay Pettitt"prospector:1525:744667"
Katrina-Kay Pettitt edited on 17 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 May, 2022
Vitalii Mazuryk
Vitalii Mazuryk edited on 2 May, 2022
Edits made to:
Infobox (+18 properties)
Infobox
Email address
info@ranitherapeutics.commedia@ranitherapeutics.compartners@ranitherapeutics.com
Full address
2051 Ringwood Ave. San Jose CA, 95131, USA
Phone number
408-457-3700
Golden logo
By using this site, you agree to our Terms & Conditions.